drugset / Trial / NCT03408262

Clinical Trial of HIV Vaccine Combinations in Healthy Men and Women

NCT03408262

Phase 1 Completed 68 enrolled Imperial College London
RandomizedParallel-groupSingle-blindPrevention

Summary

A Phase I Single-Blind randomised trial investigating immunisation strategies using Ad4-EnvCN54, MVA-CN54 and CN54gp140/MPLA combinations in order to maximise antibody responses to Human Immunodeficiency Virus

Timeline

Start
2017-10-06
Primary completion
2020-02-10
Completion
2020-02-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ad4-EnvCN54 Unknown Oral
Subject MVA-CN54 Unknown Intramuscular
Background MPLA Unknown Intramuscular